Remyelinating drug could improve vision in patients with multiple sclerosis ...Middle East

A team led by a biomedical scientist at the University of California, Riverside, reports a drug -- an estrogen receptor ligand called indazole chloride (IndCl) -- has the potential to improve vision in patients with multiple sclerosis, or MS. The study, performed on mice induced with a model of MS and the first to investigate IndCl's effect on the pathology and function of the complete afferent visual pathway, is published in Brain Pathology.

Hence then, the article about remyelinating drug could improve vision in patients with multiple sclerosis was published today ( Wednesday 03/02/2021 - 01:30 AM ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Remyelinating drug could improve vision in patients with multiple sclerosis )

Also on site :

• What the US strike in Venezuela means for gas prices and the largest proven oil reserve on the planet
• Ukraine-Russia war latest: Zelensky and Starmer discuss how to spend billions seized from Abramovich after Chelsea sale
• Multiple explosions heard in Venezuelan capital (VIDEO)